Brain morphological and functional features in cognitive subgroups of schizophrenia.


Journal

Psychiatry and clinical neurosciences
ISSN: 1440-1819
Titre abrégé: Psychiatry Clin Neurosci
Pays: Australia
ID NLM: 9513551

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 03 06 2019
revised: 30 10 2019
accepted: 26 11 2019
pubmed: 4 12 2019
medline: 15 12 2020
entrez: 4 12 2019
Statut: ppublish

Résumé

Previous studies have reported different brain morphologies in different cognitive subgroups of patients with schizophrenia. We aimed to examine the brain structures and functional connectivity in these cognitive subgroups of schizophrenia. We compared brain structures among healthy controls and cognitively deteriorated and preserved subgroups of patients with schizophrenia according to the decline in IQ. Connectivity analyses between subcortical regions and other brain areas were performed using resting-state functional magnetic resonance imaging among the groups. Whole brain and total cortical gray matter, right fusiform gyrus, left pars orbitalis gyrus, right pars triangularis, left superior temporal gyrus and left insula volumes, and bilateral cortical thickness were decreased in the deteriorated group compared to the control and preserved groups. Both schizophrenia subgroups had increased left lateral ventricle, right putamen and left pallidum, and decreased bilateral hippocampus, left precentral gyrus, right rostral middle frontal gyrus, and bilateral superior frontal gyrus volumes compared with controls. Hyperconnectivity between the thalamus and a broad range of brain regions was observed in the deteriorated group compared to connectivity in the control group, and this hyperconnectivity was less evident in the preserved group. We also found hyperconnectivity between the accumbens and the superior and middle frontal gyri in the preserved group compared with connectivity in the deteriorated group. These findings provide evidence of prominent structural and functional brain abnormalities in deteriorated patients with schizophrenia, suggesting that cognitive subgroups in schizophrenia might be useful biotypes to elucidate brain pathophysiology for new diagnostic and treatment strategies.

Identifiants

pubmed: 31793131
doi: 10.1111/pcn.12963
pmc: PMC7065166
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

191-203

Subventions

Organisme : International Research Center for Neurointelligence (WPI-IRCN)
Organisme : Grants-in-Aid for Scientific Research
Organisme : Health and Labor Sciences Research Grants
Organisme : Brain/MINDS
ID : JP19dm0207069
Organisme : Brain/MINDS
ID : JP18dm0207006

Informations de copyright

© 2019 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.

Références

Neuropsychopharmacology. 2011 Jan;36(1):316-38
pubmed: 20844478
Curr Top Med Chem. 2012;12(21):2324-38
pubmed: 23279173
Schizophr Bull. 2017 Mar 1;43(2):436-448
pubmed: 27445261
JAMA Psychiatry. 2016 Dec 1;73(12):1251-1259
pubmed: 27829096
Mol Psychiatry. 2016 Apr;21(4):547-53
pubmed: 26033243
Schizophr Res. 2014 Jun;156(1):76-86
pubmed: 24794883
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Schizophr Res. 2013 Oct;150(1):42-50
pubmed: 23911259
Arch Gen Psychiatry. 2000 Sep;57(9):907-13
pubmed: 10986554
Neurosci Biobehav Rev. 2011 Jan;35(3):573-88
pubmed: 20620163
Schizophr Res. 2013 Oct;150(1):3-10
pubmed: 23800613
Schizophr Bull. 2012 Mar;38(2):304-15
pubmed: 20624752
Neuroinformatics. 2016 Jul;14(3):339-51
pubmed: 27075850
Schizophr Res. 2012 May;137(1-3):124-31
pubmed: 22425035
Transl Psychiatry. 2018 Jan 10;8(1):20
pubmed: 29317603
Schizophr Res. 2012 Jul;138(2-3):128-35
pubmed: 22542243
Am J Psychiatry. 2012 Oct;169(10):1092-9
pubmed: 23032387
Schizophr Res. 2014 Feb;152(2-3):339-43
pubmed: 24439000
Schizophr Bull. 2017 Mar 1;43(2):355-364
pubmed: 27369471
World Psychiatry. 2014 Oct;13(3):224-32
pubmed: 25273286
Psychiatry Clin Neurosci. 2017 May;71(5):293
pubmed: 28470914
Schizophr Res Cogn. 2015 Dec 07;3:20-25
pubmed: 28740804
Front Psychiatry. 2015 Apr 21;6:53
pubmed: 25954208
Front Syst Neurosci. 2010 May 14;4:13
pubmed: 20577591
Front Psychiatry. 2018 Jun 05;9:178
pubmed: 29922185
Psychiatry Clin Neurosci. 2017 May;71(5):318-327
pubmed: 28294477
Schizophr Bull. 2011 Sep;37 Suppl 2:S33-40
pubmed: 21860045
Neuroimage Clin. 2014 Aug 23;6:134-44
pubmed: 25379425
Brain Struct Funct. 2010 Jun;214(5-6):655-67
pubmed: 20512370
Mol Psychiatry. 2016 Oct;21(10):1460-6
pubmed: 26782053
Schizophr Res. 2018 Dec;202:180-187
pubmed: 30005932
Sci Rep. 2018 Jan 19;8(1):1183
pubmed: 29352126
Schizophr Bull. 2011 Mar;37(2):306-15
pubmed: 21131368
Neuroimage. 2012 Feb 1;59(3):2142-54
pubmed: 22019881
Psychiatry Clin Neurosci. 2006 Jun;60(3):332-9
pubmed: 16732750
Psychiatry Clin Neurosci. 2017 May;71(5):294-300
pubmed: 27804186
Brain Struct Funct. 2016 Jan;221(1):447-61
pubmed: 25362539
Front Psychiatry. 2017 Dec 22;8:293
pubmed: 29312019
Biol Psychiatry. 2003 Feb 1;53(3):244-53
pubmed: 12559658
Neuroscience. 2015 Sep 10;303:82-102
pubmed: 26116523
Magn Reson Med. 1996 Mar;35(3):346-55
pubmed: 8699946
Neuroimage. 2012 Aug 15;62(2):774-81
pubmed: 22248573
Ann N Y Acad Sci. 2003 Apr;985:445-60
pubmed: 12724176

Auteurs

Yuka Yasuda (Y)

Life Grow Brilliant Mental Clinic, Medical Corporation Foster, Osaka, Japan.
Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Osaka, Japan.

Naohiro Okada (N)

Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
World Premier International-International Research Center for Neurointelligence (WPI-IRCN), The University of Tokyo Institutes for Advanced Study (UTIAS), The University of Tokyo, Tokyo, Japan.

Kiyotaka Nemoto (K)

Department of Psychiatry, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.

Masaki Fukunaga (M)

Division of Cerebral Integration, National Institute for Physiological Sciences, Okazaki, Japan.

Hidenaga Yamamori (H)

Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Japan Community Health Care Organization (JCHO), Osaka, Japan.
Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.

Kazutaka Ohi (K)

Department of Neuropsychiatry, Kanazawa Medical University, Ishikawa, Japan.
Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan.

Daisuke Koshiyama (D)

Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Noriko Kudo (N)

Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.

Tomoko Shiino (T)

Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.

Susumu Morita (S)

Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
World Premier International-International Research Center for Neurointelligence (WPI-IRCN), The University of Tokyo Institutes for Advanced Study (UTIAS), The University of Tokyo, Tokyo, Japan.

Kentaro Morita (K)

Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Hirotsugu Azechi (H)

Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.

Michiko Fujimoto (M)

Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.

Kenichiro Miura (K)

Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.

Yoshiyuki Watanabe (Y)

Department of Future Diagnostic Radiology, Osaka University Graduate School of Medicine, Osaka, Japan.

Kiyoto Kasai (K)

Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
World Premier International-International Research Center for Neurointelligence (WPI-IRCN), The University of Tokyo Institutes for Advanced Study (UTIAS), The University of Tokyo, Tokyo, Japan.

Ryota Hashimoto (R)

Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Osaka, Japan.
Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH